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Single cell transcriptomic profiling of large
intestinal enteroendocrine cells in mice e
Identification of selective stimuli for insulin-like
peptide-5 and glucagon-like peptide-1
co-expressing cells
Lawrence J. Billing 1,3, Pierre Larraufie 1,3, Jo Lewis 1, Andrew Leiter 2, Joyce Li 2, Brian Lam 1, Giles SH. Yeo 1,
Deborah A. Goldspink 1, Richard G. Kay 1, Fiona M. Gribble 1,**, Frank Reimann 1,*
ABSTRACT
Objective: Enteroendocrine cells (EECs) of the large intestine, found scattered in the epithelial layer, are known to express different hormones,
with at least partial co-expression of different hormones in the same cell. Here we aimed to categorize colonic EECs and to identify possible
targets for selective recruitment of hormones.
Methods: Single cell RNA-sequencing of sorted enteroendocrine cells, using NeuroD1-Cre x Rosa26-EYFP mice, was used to cluster EECs from
the colon and rectum according to their transcriptome. G-protein coupled receptors differentially expressed across clusters were identified, and,
as a proof of principle, agonists of Agtr1a and Avpr1b were tested as candidate EEC secretagogues in vitro and in vivo.
Results: EECs from the large intestine separated into 7 clear clusters, 4 expressing higher levels of Tph1 (enzyme required for serotonin (5-HT)
synthesis; enterochromaffin cells), 2 enriched for Gcg (encoding glucagon-like peptide-1, GLP-1, L-cells), and the 7th expressing somatostatin
(D-cells). Restricted analysis of L-cells identified 4 L-cell sub-clusters, exhibiting differential expression of Gcg, Pyy (Peptide YY), Nts (neuro-
tensin), Insl5 (insulin-like peptide 5), Cck (cholecystokinin), and Sct (secretin). Expression profiles of L- and enterochromaffin cells revealed the
clustering to represent gradients along the crypt-surface (cell maturation) and proximal-distal gut axes. Distal colonic/rectal L-cells differentially
expressed Agtr1a and the ligand angiotensin II was shown to selectively increase GLP-1 and PYY release in vitro and GLP-1 in vivo.
Conclusion: EECs in the large intestine exhibit differential expression gradients along the crypt-surface and proximal-distal axes. Distal L-cells
can be differentially stimulated by targeting receptors such as Agtr1a.
 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords Single cell RNA-sequencing; Enteroendocrine cells; Glucagon-like peptide-1 (GLP-1); Insulin-like peptide-5 (Insl5); Serotonin (5-HT)
1. INTRODUCTION
Enteroendocrine cells (EECs) are a rare subset of gastrointestinal
epithelial cells that regulate physiological processes including intesti-
nal motility and secretion, glycemia, and appetite. They represent a
diverse cellular population, collectively producing more than twenty
different hormones [1,2]. Gut hormone secretion after a meal is
stimulated by nutrient absorption and is dominated by EECs from the
small intestine, whereas the physiological role of the large number of
EECs in the large intestine is less clear. However, EECs and the hor-
mones they produce are candidate targets for drug development, as
highlighted by the success of therapies based on Glucagon-like
peptide-1 (GLP-1) for the treatment of type 2 diabetes and obesity. The
aim of this project was to improve our understanding of the physiology
of EECs in the large intestine (colon and rectum) and whether they
could usefully be targeted therapeutically.
EEC populations vary along the length of the gastrointestinal (GI) tract,
with some hormones produced predominantly in the proximal gut (e.g.
Glucose-dependent insulinotropic polypeptide, GIP) and others pre-
dominating more distally (e.g. Peptide YY, PYY; GLP-1; Insulin-like
peptide-5, INSL5) [3]. Recent transcriptomic analyses have challenged
the traditional notion that distinct EEC subtypes exist, which produce
separate and non-overlapping sets of gut hormones [4]. Character-
ization of individual EECs in the small intestine by single cell RNA-
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sequencing (scRNA-seq), led to the identification of distinct EEC sub-
groups by cluster analysis, exhibiting overlapping expression profiles
for known gut hormones [5e7]. For example, Glass et al. found that
subgroups of cells expressing Gcg (encoding GLP-1), classically known
as L-cells, also expressed Gip (considered a product of K-cells) as well
as Tph1 (tryptophan hydroxylase-1), the enzyme required for serotonin
(5-HT) production, implying overlap between L, K, and enterochro-
maffin (Ecm) cells [5]. Immunohistological and flow cytometric studies
confirmed that these overlaps identified by transcriptomics were also
reflected at the level of protein synthesis [8e10]. Most previous in-
vestigations, however, have focused on the small intestine rather than
the colon.
In the large intestine, enterochromaffin cells have been reported as the
most prevalent subtype of EEC [11]. These cells are defined by pro-
duction of 5-HT, which exerts a critical role in regulating GI motility and
peristalsis and has been associated both with irritable bowel syndrome
(IBS) and inflammatory bowel disease (IBD) [12,13]. L-cells are also
highly abundant, and distinguishable by their production of GLP-1 and
PYY, peptides known to suppress appetite and stimulate insulin
secretion [11,14e19]. A third and rarer population known as D-cells
produces somatostatin (SST) [11], which acts as a paracrine inhibitor
of other EECs and excitatory cells and influences colonic motility [20e
23]. Recently, we showed that approximately half of all large intestinal
L-cells produce INSL5, suggesting the existence of at least two sub-
groups of L-cells in this region [24,25]. Expression of Insl5 was
restricted to the large intestine and absent in other regions of the GI
tract. Large intestinal EECs are likely to sense different physiological
stimuli compared with those located more proximally, as ingested
nutrients do not normally reach the distal gut in high quantities, and
resident microbiota produce a variety of alternative candidate signaling
molecules.
EECs are generated alongside other intestinal epithelial cells by the
continuous division of crypt stem cells, and in the duodenum and
jejunum have been reported to have a life span of 3e10 days before
they are shed into the lumen from the villus tips [26,27], although a
recent paper has shown longer life spans of EECs compared to sur-
rounding enterocytes in the small intestine [28]. Small intestinal EEC
development and maturation has been modeled using 3-dimensional
intestinal organoid cultures, revealing that L-cells and Ecm cells
mature as they migrate from crypts into villi, developing increased
expression of Sct (secretin), accompanied by reductions of Gcg
expression in L-cells and of Tac1 (tachykinin) in Ecm cells [7,28]. Large
intestinal epithelium, by contrast, is characterized by deep crypts and
no villi, and reports that EECs in this region have longer life spans of
about three weeks [29] suggest some differences in EEC maturation
compared with the small intestine.
In this study, we mapped large intestinal EECs cells using single cell
RNA-sequencing. We identified different subpopulations of L-cells and
Ecm-cells, and showed that these likely represent cellular gradients
mapping along the proximal-distal and crypt-surface gut axes. Se-
lective stimulation of distal L-cells using Angiotensin-II resulted in
significant elevation of plasma GLP-1 levels, suggesting that these
cells can contribute to circulating gut hormone concentrations despite
their distal location.
2. METHODS
2.1. Animal work and ethics
All animal procedures were approved by the University of Cambridge
Animal Welfare and Ethical Review Body and carried out in accordance
with the Animals (Scientific Procedures) Act 1986 Amendment
Regulations (SI 2012/3039). The animal work was performed under
the UK Home Office project licences 70/7824 and PE5OF6065 [30,31].
Mice were housed in ventilated cages on a 12hr light/dark cycle (lights
out at 07:00 GMT) with ad libitum access to water and regular chow
(unless otherwise stated) and were culled by an approved Schedule 1
method.
2.2. Flow cytometry
Single cell digests of mouse colon were prepared for FACS purification
by two incubations of 30 min with 1 mg/ml collagenase (dissolved in
calcium-free HBSS) at 37 C. After each incubation, single cells were
harvested in the media, washed in calcium-free HBSS with 10% FBS
and filtrated through 50 mm filters. The two digests were spun at 300 g
for 10 min at 4 C and resuspended together in HBSS (calcium-free)
with 10% FBS and stained 5 min on ice with DAPI (1 mg/mL) and
washed once before being resuspended in HBSS with 10% FBS,
10 mM Y-27632 and 5 mM Draq5 (Biolegend)
The single cell suspension was sorted using an Influx Cell Sorter (BD
Biosciences) at the Cambridge Institute of Medical Research (CIMR)
Flow Cytometry Core Facility. DAPI-staining, DRAQ5-staining, side
scatter, forward scatter and pulse width gates were applied to remove
clustered cells, dead cells and cellular debris present. Neurod1-
expressing cells (from a NeuroD1-Cre x Rosa26-EYFP mouse,
henceforth called NeuroD1EYFP) were purified by EYFP fluorescence
into LoBind tubes (Eppendorf) with 40 ml HBSS (calcium-free), 10%
FBS and 10 mM Y-27632 [30,31].
2.3. Single-cell RNA-sequencing
2.3.1. Library preparation and sequencing
3500 FACS-purified NeuroD1EYFP cells (from a single mouse colon)
were loaded onto the Chromium system (10x Genomics 30 GEX V2) to
produce cDNA libraries, which were paired-end sequenced (26:8:98)
by a HiSeq 4000 (Illumina) at the Cancer Research UK Cambridge
Institute (CRUK CI). Quality control, read alignment (with reference to
the mm10 genome downloaded from the UCSC genome browser [32])
and raw count quantification for each cell was achieved using the
CellRanger pipeline (10x Genomics).
2.3.2. scRNA-seq analysis
Analyses from raw counts were performed using the Seurat package
(v2.3.4, Butler et al., 2018 Nat biotechnologies) in R using default
parameters except when indicated. Cells were first filtered based on
their total number of expressed genes (min ¼ 800), nUMI (unique
molecular identifiers; min¼ 1250, max ¼ 3rd quartileþ interquartile)
and the percentage of mitochondrial genes (between 1 and 7.5%). A
first analysis was performed using standard normalization to retrieve
the list of genes that are differently expressed (DE) in at least one
population. As DE genes accounted for a majority proportion of UMIs,
cells were further filtered on their number of UMI matching DE based
on a first analysis with standard normalization (min 800). Moreover,
UMI normalization was performed based on the number of UMI
matching nonDE genes rather than the total number of UMIs per cell.
The total number of cells of filtering was 1560.
Clusters were identified by shared nearest neighbor clustering opti-
mization using the 7 most variable dimensions of a principal compo-
nent analysis performed on the most variable genes. Populations were
plotted using t-SNE dimension reduction or expression of specific
genes plotted on distribution plots or heatmaps. Differentially
expressed genes (FDR of 5%) were assessed using a Wilcoxon rank
test between individual populations against the rest of the cells or
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between two specific populations or groups of populations with a log-
two-fold difference between each group of at least 0.2.
Subpopulations were analyzed by subsetting the cells based on cluster
annotation during first analysis and performed as the general one,
using appropriate numbers of dimensions when identifying the
clusters.
2.4. Real-time quantitative PCR (RT-qPCR)
Tissue samples were harvested from the colon divided into seven equal
parts along the proximo-distal axis (P1eP7) and lysed using TRI-reagent.
RNA was extracted by adding chloroform and collecting the aqueous
phase while proteins and peptides were retained in the phenol phase.
RNA was purified by isopropanol and ethanol precipitation and resus-
pended in nuclease free water and treated with DNA-free DNA removal kit
(Invitrogen) to remove residual genomic DNA. RNA was reverse tran-
scribed using SuperScript II using a Peltier Thermal Cycler-225 (MJ
Research) according to standard protocols. The RT-qPCR reaction
mix consisted of template cDNA, TaqMan Universal Master Mix
(Applied Biosystems) and specific primers (Applied Biosystems) for
b-actin (Mm02619580_g1), Insl5 (Mm00442241_m1), Gcg
(Mm01269055_m1), Pyy (Mm00520716_g1), Nts (Mm00481140_m1),
Cck (Mm00446170_m1), Tph1 (Mm01202614_m1), Sct
(Mm00441235_g1), Sst (Mm00436671_m1), Tac1 (Mm01166996_m1),
Piezo2 (Mm01265858_m1), Ffar1 (Mm00809442_s1), Agtr1a
(Mm01957722_s1) and Avpr1b (Mm01700416_m1) and qPCR were
performed and analyzed using an ABI QuantStudio 7 (Applied Bio-
systems). Relative expression was evaluated by calculating the difference
in cycle threshold (DCT) between the housekeeper gene b-actin and the
gene of interest (CTb-actin-CTGene).
2.5. Peptide extraction
Proteins were extracted from the phenol phase (after DNA precipitation
by ethanol) by incubation with ice-cold acetone for 10 min at 4 C
followed by centrifugation for 10 min, 12000 g. Following a wash in
0.3 M guanidine HCl (dissolved in 95% ethanol), the resulting pellet
was air dried and resuspended in 8 M urea using a syringe. Then 80%
acetonitrile was then added to each sample to precipitate proteins and
peptides in solution recovered and dried using a centrifugal concen-
trator [3]. Peptides were resuspended in 500 mL 0.1% formic acid and
spiked with internal standards and purified by solid phase extraction
using a prime HLB melution plate (Oasis) and eluted in 60 mL 60%
methanol, 30% H2O, and 10% acetic acid. Peptides were dried and
reduced-alkylated by incubation 1 h with 10 mM DTT in 50 mM
ammonium bicarbonate at 60 C followed by 30 min incubation with
20 mM iodoacetamide. Samples were further diluted with 0.1% formic
acid and 10 mL were analyzed using a nano-flow rate by a Thermo-
Fisher Ultimate 3000 nano LC system coupled to a Q Exactive Plus
Orbitrap mass spectrometer (Thermo Scientific) [3,33]. Peptide
quantification was achieved using XCalibur (ThermoFisher) to integrate
the peak area for selected sets ofm/z values at specific retention times
for each individual peptide.
For the LC-MS/MS peptide quantification, treatment supernatants were
first acidified with 50 ml 1% formic acid while homogenates were
resuspended in 500 ml 0.1% formic acid. Both were subsequently
spiked with internal standards. Subsequently peptides were extracted
and analyzed following reduction/alkylation as described previously
[3,34]. Total protein content was calculated from lysate supernatants
using a BCA protein assay (Thermo Fisher Scientific) which was used
to normalize secretory responses from different wells. In several cases
surrogate peptides, chosen on the basis of their robust observable
signal, are reported and considered to be produced from the pro-
peptide in a stable molar ratio to the established hormones. For
Gcg, we chose oxyntomodulin (Figure 3) and GRPP (Figure 4) as the
GLP-1 signal was low and split between amidated and non-amidated
forms; for CCK we chose CCK21_44, as sulfated CCK8 was not
detectable in the LC-MS/MS mode needed for the other peptides; for
INSL5, we chose the C-chain.
2.6. Immunohistochemistry
Colonic wholemounts were processed using adapted methods detailed
by Winton et al. (1990) [35]. Briefly, following isolation of the epithelial
layer, the colons were fixed for 3 h at room temperature using 4% PFA
(Alfa Aesar). Next, residual mucus was removed from the fixed tissue
by incubation with 50 ml of demucifying solution (10% glycerol, 10%
0.1 M Tris titrated to pH 8.2, 20% ethanol, 92 mM NaCl, and 20 mM
DTT) for 20 min at room temperature followed by PBS washes. Af-
terward, the fixed colons were placed in blocking solution (PBS with
0.1% Triton-X 100 and 10% goat serum) overnight at 4 C. The next
day, the colons were incubated for 4 h at room temperature with
primary antibodies to PYY (guinea pig; Progen 16066; 1:500), INSL5
(rat; Takeda; 1:1000), and NTS (rabbit; Merck; AB4596; 1:100) diluted
in wash solution containing 1% goat serum and 0.1% Triton-X 100 in
PBS. Tissues were washed overnight and then incubated with 1:300
goat secondary antibodies (conjugated to AlexFluor 488, 555 and 633)
for 3 h at room temperature. Following further washing overnight at
4 C, the colons were incubated with 1:2000 Hoescht nuclear stain (in
PBS) for 30 min at room temperature followed by PBS washes. Finally,
the colons were divided in half and mounted onto microscope slides
using Hydromount (National Diagnostics).
2.7. Imaging of colonic wholemounts
2.7.1. Image acquisition
Wholemounts were imaged using the Axio Scan.Z1 system (Zeiss).
Tiles of extended depth of focus (EDF) images were taken for each of
the three labeled channels using a Plan-ApoChromat 20x/0.8 M27
objective, a Hamamatsu Orca Flash camera, and an inbuilt autofocus
function. The depths used for the EDF images were customized for
each wholemount and depended on tissue thickness. Following
acquisition, the tiled images were stitched together with shading
correction.
2.7.2. Counting of immunofluorescently labeled cells
For analysis of cell populations from stained whole-mount tissue, 10
ROIs (0.5 mm  0.5 mm picked based on in focus Hoescht staining)
where selected from proximal, mid and distal areas of the large in-
testine from 3 mice (total ROIs ¼ 90) and the number of cells for each
population counted using HALO software (Indica Labs). For automated
analysis, thresholding and size criteria were kept the same for all 3
channels and the number of cells per ROI for each of the channels was
then calculated. Cell density per region was then analyzed using a
combination of Excel (Microsoft Office) and GraphPad Prism 7.0
(GraphPad Software).
2.8. Primary cultures
Excised murine large intestines were collected in Leibovitz’s L-15
media and divided into three equal segments. Segments from the
same region from 2 different mice were pooled together to ensure
enough tissue for each secretion plate. Colonic crypts were subse-
quently isolated from each region as described previously [36]. Briefly,
isolated tissue was cleaned of contents in PBS containing CaCl2 and
MgCl2 and the epithelium was separated from adipose, the outer
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muscle layers and vasculature by manual stripping. Following this, the
tissue was cut into small chunks (w2 mm2) and digested using
collagenase XI (Sigma; 0.25 mg/ml). Isolated colonic crypts were
resuspended in DMEM enriched with glucose (4500 mg/L), 10% FBS,
1% glutamine, and 1% penicillin/streptomycin and plated onto 2%
matrigel (Corning) precoated 12 well plates. Plated crypt suspensions
were placed into a 37 C humidified incubator with 5% CO2 to settle
overnight prior to experimentation.
2.9. Secretion assays
For the secretion assays, colonic crypt cultures were processed as
described in Billing et al. [25]. Briefly, following washes with saline
buffer containing 1 mM glucose and 0.001% fatty acid free BSA, each
well of colonic crypts was incubated with 600 ml of each treatment
(made up in saline buffer and 0.001% BSA) at 37 C for 1 h. Super-
natants were collected in protein LoBind 1.5 ml tubes (Eppendorf) and
centrifuged at 2000 g for 5 min at 4 C to remove cellular debris.
500 ml of each supernatant were collected into fresh 1.5 ml LoBind
tubes. Meanwhile, 200 ml lysis buffer was added to each well. After
30 min on ice, the plates were snap frozen and defrosted to ensure
complete cell lysis. Lysates were collected following cell scraping and
spun at 2000 g for 5 min at 4 C and the supernatants were retained.
Both supernatants and lysates were stored at 80 C prior to further
processing. Protein content from lysates was analyzed by BCA assay
(Pierce) and used to normalize for cell density variability between wells.
100 mL 1% formic acid and internal standards were added to super-
natants and peptides were extracted by solid phase extraction and
reduced alkylated as described previously. 40 mL of 120 mL were
analyzed by nano-LC-MS/MS as described previously and peptide
content quantified by measuring the peak area corresponding to
characterized peptides. The experiment was performed five times with
duplicates for each condition. Each peptide was analyzed separately
and two-way ANOVA followed by a Tukey’s test were performed to test
significant differences between responses.
2.10. In vivo stimulation test
Adult male and female mice, obtained from a C57Bl6 colony main-
tained at the University of Cambridge, were fasted overnight (16 h) with
free access to water. AVP (V9879, Sigma - 100 ng per mouse),
angiotensin II (A9525, Sigma - 1 mg/kg BW) or vehicle (saline) were
administered via intraperitoneal injection. For measurement of GLP-1
(cross-over design) and PYY levels (independent experiment, due to
the greater plasma volume required for the assay), 50 and 80 ml of
blood were collected from the tail vein into heparin-coated tubes
15 min post administration. Plasma was separated by centrifugation at
4 C and snap frozen on dry ice, before storage at 80 C. Plasma
GLP-1 and PYY were measured in 20 and 40 ml respectively by non-
competitive two-site immunoassay (MesoScale Discovery/CBAL UK).
Data were analyzed by Student’s paired and unpaired t-test for GLP-1
and PYY, respectively.
3. RESULTS
3.1. EEC heterogeneity in the colon
EECs from a Neurod1-cre mouse crossed with a Rosa26-EYFP reporter
mouse colon were flow-sorted and single-cell RNA-seq was performed
using the 10xGenomics 30 GEX V2 platform (see methods) (Figure 1A).
Data were analyzed using the Seurat R package with modifications as
described in material and methods. Cluster analysis identified 7 EEC
subgroups (Figure 1B). Gut hormones were amongst the top differ-
entially expressed genes distinguishing clusters, including Gcg, Nts
(neurotensin), Insl5, Pyy, Cck (cholecystokinin), Sst, Sct, Tac1, and
Tph1 (Suppl. Figure S1AeC and Figure 1C). Four clusters expressed
high levels of Tph1, identifying them as Ecm cells (790/1560 cells,
w50%), two clusters were enriched for Gcg and Pyy characteristic of
L-cells (609/1560 cells,w40%), and the remaining cluster expressed
high levels of Sst (D-cells, 161/1560 cells,w10%) (Figure 1C). Each of
the clusters expressed specific set of genes with the top5 being
presented in Suppl. Figure S1A.
Two of the four Ecm-cell clusters showed enrichment for the
expression of the mechanosensitive ion channel Piezo2 and have been
denoted as EcmPzþ, with the two Piezo2-negative clusters denoted
EcmPz. Both Piezo-positive and Piezo-negative cells sub-clustered
into groups that were enriched for either Sct or Tac1, resulting in
clusters labeled EcmPzþ/Sct, EcmPzþ/Tac, EcmPz/Sct, and EcmPz/Tac
(Figure 1C).
Comparing the two L-cell clusters, one expressed high levels of Nts
and Cck (denoted LNts-cells) whereas the other had high levels of Insl5
(LInsl5-cells) (Figure 1C). When the L-cell clusters were further analyzed
after exclusion of all other EECs, additional sub-clustering was
observed (Figure 1D and Suppl. Figure S1D). LNts-cells separated into
two groups, one with higher Nts, Pyy, and Sct (LNts/Sct) and the other
with higher Gcg (LNts/Gcg). LInsl5 cells similarly separated into a group
with higher Pyy and Sct (LInsl5/Sct) and one with higher Gcg (LInsl5/Gcg)
(Figure 1E).
Analysis of the D-cell cluster without other EEC sub-types did not
reveal further D-cell sub-clusters. Differential expression heatmaps of
G-protein coupled receptors (GPCRs) and transcription factors across
all 7 EEC clusters, as well as across the four L-cell sub-clusters
analyzed separately, are shown in Suppl. Figure S1.
3.2. Common transcriptomic patterns defining different EEC
subgroups
We hypothesized that our observation of Ecm and L-cell clusters with
differential expression of Sct, Tac1 (in Ecm cells), and Gcg (in L-cells)
reflects cellular maturation along the crypt-surface axis in the colon
and rectum, mirroring the recently described maturation of small in-
testinal EECs [7,28]. We examined whether the acquisition of Sct
expression in L-cells is accompanied by other transcriptional changes
that are common between LNts and LInsl5 cells (Figure 2A), restricting
our analysis to genes showing an absolute log2 fold-change (L2FC) of
>0.2 in both Sct/Gcg pairs and reaching a significant difference in at
least one of the Sct/Gcg pairs. Genes enriched in LNts/Sct cells (vs LNts/
Gcg) correlated positively with those enriched in LInsl5/Sct cells (vs LInsl5/
Gcg), with Sct and Gcg exhibiting the most extreme regulation between
these clusters. Other genes highlighted by the analysis included the
transcription factors Id (inhibitor of differentiation) -1,2,3, which were
higher in Sct-enriched clusters, and Nr4a1, which was higher in Gcg-
enriched clusters.
We performed a similar analysis of Ecm cell clusters to examine
whether the acquisition of Sct and loss of Tac1 expression is
accompanied by other common transcriptional changes between
Piezo2-positive and negative Ecm clusters (Figure 2B). This compari-
son showed reasonable correlation, with several genes being up- and
down-regulated in parallel with Sct and Tac1. Genes enriched in the
Sct-groups (Cdkn1a, Smad7) have been described as markers of
colonic surface epithelium, whereas genes in the Tac1-cluster
(Sec61b, Atf6) have been located towards the bottom of colonic crypts
[37], consistent with the idea that downregulation of Tac1 expression
and upregulation of Sct occurs during Ecm cell maturation in the colon
and rectum. A similar analysis comparing all L- and Ecm-cells, each
grouped by their Sct-expression status, also showed a reasonable
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correlation, revealing an overlapping set of genes (Figure 2C) sug-
gesting that these genes are commonly regulated along the crypt-
surface epithelial axis in colonic EECs.
We next examined, independent of these maturity markers, what
separated L-cells into high Insl5 vs high Nts groups and Ecm cells into
Piezo2-positive vs Piezo2-negative groups (Figure 2D). A differential
expression analysis, performed as above but comparing genes
enriched in Piezo2 positive (vs negative) Ecm cells with those enriched
in Insl5-positive L-cells (vs LNts cells), revealed parallel transcriptional
changes in EcmPzþ cells and LInsl5 cells. This comparison identified a
number of Homeobox B (Hoxb) genes which are known to be involved
in rostro-caudal differentiation thereby defining the proximal to distal
axis in the large intestine, with higher Hoxb numbers assigned to more
distal locations [38,39]. Hoxb6, Hoxb7, and Hoxb8 were higher in
Figure 1: Identification of colonic enteroendocrine cell clusters. (A) FACS output from the NeuroD1 sort. Sorted fluorescent EYFP cells w0.58% of parent population following
forward/side scatter, DRAQ5 and DAPI gating. 7000 EYFPþve cells were isolated in one FACS run from one NeuroD1-EYFP mouse. 3500 of these cells were put into the Chromium
10x system. (B) t-SNE plot of identified cell clusters from scRNA-seq analysis of FACS-isolated NeuroD1 expressing colonic cells (n ¼ 1560 cells). Clusters were identified from the
first 7 dimensions of a PCA analysis of the most variable genes using a shared nearest neighbour algorithm. (C) Heat-map of relative expression to average for the main hormone
encoding genes and markers of the Nts and Insl5 L-cell sub-clusters, D-cells, Secretin, Tac1 and Piezo2 Ecm cell sub-clusters. (D) t-SNE plot of all cells identified as L-cells from
the first clustering, with the clusters identified using an SNN algorithm on the 7 first dimensions. (E) Heat-map of relative expression to average for the main hormone encoding
genes of the L-cell sub-clusters.
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Figure 2: Common determinants of Ecm- and L-cell sub-clustering. (AeD) Correlation plots of all genes that are differently expressed in at least one comparison and for
which the L2FC is higher than 0.2 in both comparisons, plotting the log2 fold change difference between two populations plotted against the log2 fold change between two other
populations. Pearson correlation coefficient is indicated. (A) compares the difference between the LInsl5/Gcg and the LInsl5/Sct sub-clusters with the difference between the LNts/Gcg and
LNts/Sct sub-clusters, as defined during the L-cells sub-clustering. (B) compares the difference between the EcmPz/Tac cluster and the EcmPz/Sct cluster with the difference
between the EcmPzþ/Tac and the EcmPzþ/Sct clusters. (C) compares the difference between Sct-positive (LNts/Sct þ LInsl5/Sct) and Sct-negative (LNts/Gcg þ LInsl5/Gcg) L-cells with the
difference between similar Ecm sub-clusters ((ECPz/Sct þ ECPzþ/Sct) and (ECPz/Tac þ ECPzþ/Tac), respectively). (D) compares the difference between Nts-positive (LNts) and Insl5-
positive (LInsl5) L-cells with the differences between Piezo-negative (ECPz/Tac þ ECPz/Sct) and -positive (ECPzþ/Tac þ ECPzþ/Sct) Ecm-cells. (E) Violin plots of log2 normalized unique
molecular identifiers (nUMIs) counts for the original identified seven clusters for different Hoxb genes.
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EcmPz and LNts cells, suggesting they arise more proximally in the
large intestine, whereas Hoxb13 was higher in EcmPzþ and LInsl5 cells,
suggesting a more distal origin (Figure 2E).
3.3. EEC variability along the proximo-distal axis
To confirm the proximo-distal distribution of the different clusters, gene
expression and peptide levels were measured in tissue homogenates
from seven regions equally distributed along the colon/rectum, from
proximal (P1) to distal (P7) in three mice. Insl5 gene expression was
very low and the peptide undetectable in proximal regions whereas
expression and INSL5 peptide levels were significantly increased in the
distal gut (Figure 3A and B). Nts and Cck showed the opposite pattern,
with high levels in proximal regions that dropped more distally. Gcg and
Pyy (and derived peptides) only exhibited weak proximal-distal gradi-
ents along the large intestine, but, interestingly, we detected PYY3-36
as well as PYY1-36 by our LC-MS/MS analysis, and found that PYY3-36
predominated in the distal rectum, indicating region-dependent pro-
cessing. We further validated the regional distribution of L-cells by co-
staining for INSL5, NTS, and PYY in whole mounted colons (Figure 3E).
NTS positive cells were mainly localized in the proximal regions
whereas INSL5 positive cells were found in higher numbers in the distal
colon (Figure 3F). PYY positive cells were present along the large in-
testine, with no evident gradient.
Consistent with the proposed distal location of EcmPzþ cells deter-
mined from the cluster analysis, Piezo2 expression was 5 times higher
in the distal tissue samples, with the exception of the most distal
rectum. Gradients for other examined Ecm cell markers and Sst were
unremarkable (Figure 3C and D).
3.4. Selective stimulation of L-cell populations by GPCR ligands
As expression of some GPCRs was found to differ between the L-cell
clusters (Supp. Figure S1E), we examined whether selective GPCR
agonists could be used to trigger region-specific hormone secretion
from the colon or rectum. We selected the arginine-vasopressin (AVP)
receptor Avpr1b and the angiotensin2 (AngII) receptor Agtr1a, which
were enriched in LInsl5 compared with LNts cells, and the free fatty acid
receptor Ffar1, which was expressed in both L-cell clusters (Figure 4A)
but at lower level. Primary crypt cultures from the proximal third, the
middle third or the distal third (Figure 4CeH) of the large intestine were
stimulated with AVP (10 nM), AngII (10 nM) or AM1638 (1 mM; a strong
agonist for FFA1). Hormone secretion was quantified by a multiplex LC-
MS/MS method [25,34], and a combination of glucose (10 mM) and
IBMX (100 mM) was used as a positive control. We were unable to
detect secretin reliably with this method, perhaps reflecting the
enrichment of crypt over surface epithelial cells in these cultures, but
NTS, CCK, GLP-1, PYY, and INSL5 secretion could be monitored reli-
ably and simultaneously, through fragments derived from the
respective pro-hormones.
As expected from the expression analysis, we could not detect
secretion of NTS from distal cultures and INSL5 was only detected in a
few samples derived from proximal colon. ProCCK levels were also
lower, and PYY3-36 levels higher, in supernatants from distal vs
proximal cultures. In proximal colonic cultures, AM1638 stimulated
secretion of NTS, proCCK, GRPP (a peptide from Gcg) and PYY,
whereas AVP and AngII were largely without effect. By contrast, all
three GPCR ligands stimulated secretion of proCCK, GRPP, PYY, and
INSL5 from the distal cultures, consistent with the enrichment of
Avpr1b and Agtr1a in LInsl5, but not LNts cell clusters. Results from the
middle section fell in between the results from the proximal and distal
large intestine, both with respect to the levels of individual peptides
detected and the responsiveness to the different stimuli.
We next examined whether large intestinal L-cells could be stimulated
specifically in vivo using agonists of AVPR1B and AGTR1A. Expression
of these receptors in bulk-purified L-cells from duodenum, ileum, and
colon/rectum was assessed from our published RNA-sequencing data
[3], revealing that whereas Agtr1a expression was restricted to the
distal gut, Avpr1b was also expressed in more proximal L-cells in the
small intestine (Figure 4B). Mice were injected ip with AVP, AngII or
vehicle control, and plasma GLP-1 and PYY levels measured by
immuno-assay after 15 min. GLP-1 levels increasedw2-fold following
stimulation with either AVP or AngII (Figure 4I and J). PYY levels were
elevated significantly by AVP but not AngII (Figure 4K and L).
4. DISCUSSION
In this study, we used scRNA-seq to characterize the EEC landscape of
the mouse large intestine. Consistent with previous literature [11]
colonic EECs fall into three major groups based on their expression
of Gcg and Pyy (L-cells), Tph1 (EC-cells) or Sst (D-cells). Ecm-cells
were the most abundant cells constituting w50% of all Ecm-cells,
followed by L-cells (w40%) and the remaining w10% being D-
cells, matching previous reports.
L-cells and Ecm cells formed several distinct sub-clusters, exhibiting
transcriptional profiles consistent with the idea that they differ along
the crypt-surface and proximal-distal gut axes. Consistent with pre-
vious data from the small intestine [7,28], Sct-positive Ecm-cells
expressed lower levels of Tac1 (encoding the precursor of
neurokinin-A and substance-P), compared with other Ecm-cells,
whereas Sct-positive L-cells expressed lower levels of Gcg
compared with other L-cells. It is thus likely that the Sct/Tac and the
Sct/Gcg subgroupings in Ecm and L-cells, respectively, distinguish
surface epithelial cells from deep crypt cells in the colon and rectum.
Consistent with this hypothesis, a previous report showed enrichment
of GCG in a deep crypt preparation of the human colon compared with
surface epithelium [37], whereas we observed higher expression of
cell cycle inhibitors such as Cdkn1a in the Sct-enriched cells. A
physiological reason for this apparent hormonal switch as enter-
oendocrine cells mature is still unclear.
ScRNA-seq has recently been combined with temporally restricted
fluorescent protein expression to map transcriptional changes occur-
ring during EEC differentiation in the mouse small intestine [28].
Mirroring their data, we identified similar transcription factors specif-
ically enriched in L-cells (e.g. Arx), Ecm-cells (e.g. Atf6) and D-cells
(e.g. Hhex) from the large intestine, also consistent with our previous
reports that Hhex is enriched in Sst-positive cells in the stomach and
pancreas [40,41]. Our correlation analysis of Sct-positive vs negative
EEC clusters from the large intestine also revealed higher expression in
Sct-positive cells of transcription factors that were found by temporal
fluorescence mapping to be expressed only late in EEC development in
the small intestine [28], e.g. Id1-3 and Gtf2f2. Our results therefore
suggest that EEC development and differentiation in the colon and
rectum follow similar pathways to those previously described in the
small intestine.
In addition to the transcriptomic signatures characteristic of EEC
development along the crypt-surface axis, we found that both Ecm
cells and L-cells displayed a proximo-distal expression gradient.
Distally located L-cells characteristically expressed Insl5 rather than
Nts and processed PYY more efficiently to the shorter 3-36 form; the
physiological relevance of this hormonal signature change in the distal
large intestine remains obscure. It could be speculated that intracel-
lular processing to PYY3-36 enables more selective stimulation of Y2R
in the vicinity of L-cells before PYY1-36, which has a broader Y-
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Figure 3: Localization of INSL5, PYY, and NTS-producing cells within the colon. (A, C) Relative expression of Lcell (A) and D or Ecm-cell (C) enriched genes along the
proximal-distal axis of the murine colon divided into 7 equal segments (P1eP7) by RT-qPCR. Cycle threshold difference (DCT) was calculated between the gene of interest and the
housekeeper b-actin (CTb-actin-CTGene). (B,D) Peptide quantification by LC-MS/MS of proCCK (CCK21-44), Neurotensin, INSL5 (C-chain), Oxyntomodulin (OXM), PYY (1-36 and 3-36)
(B) and pro-SST, pro-tachykinin (TKN)1 and SCT (D) in P1eP7. (E) Representative images of proximal, middle and distal large intestine immunofluorescently labeled for NTS (blue,
left column), PYY (red, middle center column) and INSL5 (green, center right column). Merged pictures for all three regions are represented in most right column. Scale
bar ¼ 50 mm. (F) Plot showing the density (per mm2) of labeled NTS (blue), PYY (red) and INSL5 (green) cells in proximal, middle, and distal large intestine as extracted from
images as shown in (D). Data from 3 mice (indicated by different symbols), with 10 ROIs per region per mouse. Analysis by non-parametric one-way ANOVA with post hoc Dunns
multiple comparison (compared to proximal density) for each of the hormones. ***p < 0.001.
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Figure 4: Selective stimulation of distal colonic/rectal L-cells. (A) Violin plots of log2 normalized unique molecular identifiers (nUMIs) counts in the seven colonic EEC clusters
for Angiotensin-II receptor 1a (Agtr1a), Arginine-vasopressin receptor 1b (Avpr1b) and Free-fatty-acid receptor 1 (Ffar1). (B) Expression of Agtr1a and Avpr1b in Venus-labeled L-
cells and non-fluorescent cells from the same sorts isolated from the duodenum, ileum, and colon from GLU-Venus mice; data from bulk RNAseq by Roberts and collaborators [3],
shown as Log2 (normalized readsþ1) using DESeq2 normalization, data for L-cells are shown in dark red and for negative cells in light red. (CeH) Secretion of different gut
peptides as indicated in response to a FFAR1- (AM1638, 1 mM), Agtr1a- (AngII, 10 nM), and Avpr1b- (AVP, 10 nM) agonists or no stimuli or IBMX 100 mM with 10 mM glucose (IG).
Colonic primary cultures from the first, middle and final third of mouse large intestine were processed separately and stimulated in parallel. Peptides were quantified by LC-MS/MS
and normalized to the protein content of the crypt culture. * indicates a statistical difference between the condition and the basal (control condition) tested by a Tukey’s test if a
two-way ANOVA showed different populations. (IeL) Plasma GLP-1 (I, J) and PYY (K, L) levels 15 min after i.p. vehicle, AngII (1 mg/kg) (I, K) or AVP (100 ng/mouse) (J, L)
application. Data were analyzed by Student’s paired t-test for GLP-1 as mice were their own controls (cross over design) and by Student’s unpaired t-test for PYY as measurements
were performed in independent experiments. *p < 0.05, **p < 0.01 and ***p < 0.001.
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receptor repertoire [42], is processed by DPP4 expressed in endothelial
cells [43]. Ecm-cells by contrast, exhibited a strong longitudinal
gradient of Piezo2, a mechanosensitive channel previously implicated
in small intestinal Ecm-cell stretch sensitivity [44]. It is currently un-
clear why the most distally located Ecm-cells would need a higher
expression of these channels, especially as Ecm-cells seem to be
redundant for the initiation of colonic peristalsis and pellet propulsion
[45e47].
EC-cell and L-cell clusters exhibited differential expression of a number
of GPCRs. Olfr78, Olfr558, and Ffar2 were more highly expressed in
Tac1-positive than Sct-positive Ecm cells, suggesting these receptors
are predominantly located deeper in the crypts rather than the surface
epithelium. As these receptors are believed to sense microbially
generated short chain fatty acids [48e50], this raises an interesting
question of whether microbiota residing within colonic crypts are
physiologically more important for providing signals to EECs than those
resident in the lumen. Confirming a previous report examining the
expression profile of small intestinal and colonic Ecm cells [50], we
also found that GPCRs classically involved in detecting nutrient
ingestion in small intestinal L-cells, including Ffar1, Gpr119, and
Gpbar1, were expressed in large intestinal L-cell clusters but absent
from corresponding Ecm clusters.
L-cells also exhibited differential GPCR expression along the proximo-
distal axis, most notably Agtr1a and Avpr1b, which were more highly
expressed in clusters localized to the distal large intestine. These re-
ceptor expression profiles were utilized to examine whether targeted
activation of distal L-cells would be sufficient to elevate plasma GLP-1
and PYY levels in vivo. Further analysis of receptor expression in the
small intestine, however, revealed that whereas Agtr1a was indeed
restricted to large intestinal L-cells, Avpr1b was also found in small
intestinal L-cells. In vitro, we showed that AVP and AngII triggered
hormone release from rectal but not proximal colonic primary cultures.
In vivo, we were restricted to available immunoassays, as we are
currently unable to detect gut hormones at endogenous levels in
mouse plasma by LC-MS. Both AVP and AngII elevated plasma GLP-1
levels approximately 2-fold, whereas plasma PYY was elevated by AVP
but not AngII. We noted, however, that total PYY levels were relatively
high in these plasma samples, perhaps because the immuno-assay
employed polyclonal antibodies that would also detect common PYY
degradation products [51,52], making it more difficult to pick up small
increments in PYY secretion from plasma measurements. We specu-
late that AVP was the stronger PYY stimulant because it targeted some
small intestinal L-cells in addition to those in the rectum.
The response to AngII injection in mice indicates that targeted stim-
ulation of L-cells in the distal colon and rectum is sufficient to elevate
plasma GLP-1 levels in vivo. Interestingly, these distal L-cells char-
acteristically expressed Insl5 alongside Gcg and Pyy. We previously
described INSL5 to have orexigenic properties [24], contrasting with
the anorexigenic actions of co-released PYY and GLP-1 (Figure 4) [25].
Whilst the elevated GLP-1 levels following distal L-cell stimulation are
likely sufficient to exert a stimulatory effect on insulin secretion, further
studies will be required to establish the net effect on food intake of
targeting this distal L-cell population.
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